Globitair

China's Hengrui licenses weight-loss drug to Denmark's Novo Nordisk in deal worth up to $2.6B - Anadolu Ajansı

Google NewsDenmark

China's Hengrui licenses weight-loss drug to Denmark's Novo Nordisk in deal worth up to $2.6B  Anadolu Ajansı

Read the full story at Google NewsOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about Denmark